Screening compound: InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3

Screening compound: InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3
Screening compound: InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J022-0684

Molecular Formula

C21H19BrN4O2 (C21 H19 BrN4 O2)

Compound Name

4-{6-bromo-3-[(2,6-dimethylphenyl)amino]imidazo[1,2-a]pyrazin-2-yl}-2-methoxyphenol

IUPAC name

4-{6-bromo-3-[(26-dimethylphenyl)amino]imidazo[12-a]pyrazin-2-yl}-2-methoxyphenol

SMILES

Cc1cccc(C)c1Nc1c(-c(cc2)cc(OC)c2O)nc(cn2)n1cc2Br

MDL Number (MFCD)

InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

CNS Targets (44014 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Akt-Targeted Library (14764 compounds)

Carbonic Anhydrase II Library (4939 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • Epigenetic
  • PPI modulators
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3?
Check Price and Availability of InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H19BrN4O2/c1-12-5-4-6-13(2)19(12)25-21-20(14-7-8-15(27)16(9-14)28-3)24-18-10-23-17(22)11-26(18)21/h4-11,25,27H,1-3H3 available by request